Starboard Value called consumer products company Kenvue a bargain and said its skin health and beauty segment's lackluster ...

Kenvue, Inc. (KVUE – Research Report), the Technology sector company, was revisited by a Wall Street analyst yesterday. Analyst Anna ...

NEW YORK (Reuters) - Starboard Value called consumer products company Kenvue a bargain and said its skin health and beauty ...

Two analysts take opposing views on Johnson & Johnson (JNJ) spin-off Kenvue (NYSE:KVUE) and its standing within the competitive skin care and beauty category. Both Jefferies and RBC Capital see ...

Kenvue (KVUE) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended September 2024. This widely-known consensus outlook gives ...

In this update, I share my latest thoughts on Kenvue stock, focusing specifically on the Q2 2024 results that sent the stock soaring 25%. I've incorporated the latest results into my valuation ...

10 analysts have shared their evaluations of Kenvue (NYSE:KVUE) during the recent three months, expressing a mix of bullish and bearish perspectives. Summarizing their recent assessments ...

Most readers would already be aware that Kenvue's (NYSE:KVUE) stock increased significantly by 23% over the past three ...

In a report released on October 7, Nik Modi from RBC Capital maintained a Hold rating on Kenvue, Inc. (KVUE – Research Report), with a price target of $24.00. The company’s shares closed ...

Providing a diverse range of perspectives from bullish to bearish, 8 analysts have published ratings on Kenvue (NYSE:KVUE) in the last three months. The table below summarizes their recent ratings ...

Kenvue Inc. (NYSE: KVUE) (“Kenvue” or the “Company”), the maker of iconic brands such as Aveeno®, Listerine®, Neutrogena® and Tylenol®, is advancing progress toward the climate change ...